Human RANK / TNFRSF11A Protein, Mouse IgG2a Fc Tag, low endotoxin (MALS verified)
分子別名(Synonym)
CD265,FEO,LOH18CR1,ODFR,OFE,OPTB7,OSTS,PDB2,RANK,TNFRSF11A,TRANCER,CD265 antigen,ODFROSTS,RANKLOH18CR1,NFKB activator
表達區(qū)間及表達系統(tǒng)(Source)
Human RANK Protein, Mouse IgG2a Fc Tag (RAK-H5251) is expressed from human 293 cells (HEK293). It contains AA Ile 30 - Pro 212 (Accession # Q9Y6Q6-1).
Predicted N-terminus: Ile 30
蛋白結(jié)構(gòu)(Molecular Characterization)
![1.jpg 1.jpg](/SupplyImg1/2025-02-08/6387461874940799145110889.jpg)
This protein carries a mouse IgG2a Fc tag at the C-terminus.
The protein has a calculated MW of 47.2 kDa. The protein migrates as 50-55 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 0.1 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
![2.jpg 2.jpg](/SupplyImg1/2025-02-08/6387461875793248023404088.jpg)
![3.jpg 3.jpg](/SupplyImg1/2025-02-08/6387461876116424389587865.jpg)
背景(Background)
RANK/TNFRSF11A是腫瘤壞死因子受體家族的成員。RANK/TNFRSF11A在其細胞外四個富含半胱氨酸的重復序列中與TNFR家族的其他成員具有顯著的氨基酸同源性。小鼠的功能基因組學表明,RANKL(TNFSF11)是TNF配體超家族的成員,RANK(TNFRSF11a)是RANKL的同源TNFR家族受體,對體內(nèi)破骨細胞生成至關重要。由成骨細胞譜系的骨基質(zhì)細胞表達的RANKL和由造血髓系譜系的破骨細胞前體表達的RANK之間的功能相互作用是破骨細胞分化、存活和激活所必需的。
關鍵字: RANK;RANK蛋白;RANK重組蛋白;ACRO;百普賽斯;
百普賽斯集團ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領域提供關鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團業(yè)務遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個城市設有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計服務客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關系。集團旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學等。